Author:
Scott R.,Loeys T.,Davies M. J.,Engel S. S.,
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference23 articles.
1. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy;Kahn;N Engl J Med,2006
2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998
4. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;JAMA,1999
5. Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations;Riddle;Endocrinol Metab Clin North Am,2005
Cited by
182 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献